These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27084745)

  • 1. A Review on Spinal Muscular Atrophy: Awareness, Knowledge, and Attitudes.
    Moultrie RR; Kish-Doto J; Peay H; Lewis MA
    J Genet Couns; 2016 Oct; 25(5):892-900. PubMed ID: 27084745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment Experiences, Identity and Attitudes Towards Genetic Screening: the Views of People with Spinal Muscular Atrophy.
    Boardman FK; Young PJ; Griffiths FE
    J Genet Couns; 2018 Feb; 27(1):69-84. PubMed ID: 28664217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study.
    Qian Y; McGraw S; Henne J; Jarecki J; Hobby K; Yeh WS
    BMC Neurol; 2015 Oct; 15():217. PubMed ID: 26499462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population.
    Boardman FK; Sadler C; Young PJ
    Mol Genet Genomic Med; 2018 Jan; 6(1):99-108. PubMed ID: 29169204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of experiential knowledge within attitudes towards genetic carrier screening: A comparison of people with and without experience of spinal muscular atrophy.
    Boardman FK; Young PJ; Warren O; Griffiths FE
    Health Expect; 2018 Feb; 21(1):201-211. PubMed ID: 28703871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current attitudes toward carrier screening for spinal muscular atrophy among pregnant women in Eastern China.
    Li Y; Wang L; Tan J; Huang M; Wang Y; Shao B; Lv J; Zhang J
    J Genet Couns; 2023 Aug; 32(4):823-832. PubMed ID: 36775845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for spinal muscular atrophy: The views of affected families and adults.
    Boardman FK; Young PJ; Griffiths FE
    Am J Med Genet A; 2017 Jun; 173(6):1546-1561. PubMed ID: 28374951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era.
    Zettler B; Estrella E; Liaquat K; Lichten L
    J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public attitudes regarding a pilot study of newborn screening for spinal muscular atrophy.
    Rothwell E; Anderson RA; Swoboda KJ; Stark L; Botkin JR
    Am J Med Genet A; 2013 Apr; 161A(4):679-86. PubMed ID: 23443997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for spinal muscular atrophy: Anticipating an imminent need.
    Phan HC; Taylor JL; Hannon H; Howell R
    Semin Perinatol; 2015 Apr; 39(3):217-29. PubMed ID: 25979781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Carrier Screening for Spinal Muscular Atrophy.
    Wood SL; Brewer F; Ellison R; Biggio JR; Edwards RK
    Am J Perinatol; 2016 Oct; 33(12):1211-7. PubMed ID: 27611803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Research Readiness for Spinal Muscular Atrophy: The Time Is Now for Knowledge Translation.
    Krosschell KJ; Dunaway Young S; Peterson I; Curry M; Mazzella A; Jarecki J; Cruz R
    Phys Ther; 2022 Oct; 102(10):. PubMed ID: 35904447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy.
    Pacione M; Siskind CE; Day JW; Tabor HK
    J Neuromuscul Dis; 2019; 6(1):119-131. PubMed ID: 30594933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy.
    Wood MF; Hughes SC; Hache LP; Naylor EW; Abdel-Hamid HZ; Barmada MM; Dobrowolski SF; Stickler DE; Clemens PR
    Muscle Nerve; 2014 Jun; 49(6):822-8. PubMed ID: 24307279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mixed method study on the impact of living with spinal muscular atrophy in Malaysia from patients' and caregivers' perspectives.
    Ch'ng GS; Koh K; Ahmad-Annuar A; Taib F; Koh CL; Lim ESC
    Orphanet J Rare Dis; 2022 May; 17(1):200. PubMed ID: 35578241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population screening for spinal muscular atrophy: A mixed methods study of the views of affected families.
    Boardman FK; Young PJ; Griffiths FE
    Am J Med Genet A; 2017 Feb; 173(2):421-434. PubMed ID: 27792846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal muscular atrophy: a time for screening.
    Prior TW
    Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan.
    Lee T; Tokunaga S; Taniguchi N; Fujino T; Saito M; Shimomura H; Takeshima Y
    Children (Basel); 2021 Aug; 8(8):. PubMed ID: 34438585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parents' advice to healthcare professionals working with children who have spinal muscular atrophy.
    Hjorth E; Kreicbergs U; Sejersen T; Lövgren M
    Eur J Paediatr Neurol; 2018 Jan; 22(1):128-134. PubMed ID: 29146237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.